Dodge & Cox Has $471.42 Million Position in Ralliant Corporation $RAL

Dodge & Cox reduced its stake in shares of Ralliant Corporation (NYSE:RAL) by 0.2% during the 3rd quarter, HoldingsChannel reports. The fund owned 10,780,303 shares of the company’s stock after selling 17,203 shares during the period. Dodge & Cox owned 0.10% of Ralliant worth $471,423,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of RAL. JPMorgan Chase & Co. acquired a new stake in shares of Ralliant during the 2nd quarter valued at about $18,494,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS bought a new position in shares of Ralliant during the 2nd quarter valued at $1,410,000. Vanguard Group Inc. lifted its stake in shares of Ralliant by 10.7% in the 3rd quarter. Vanguard Group Inc. now owns 14,589,423 shares of the company’s stock valued at $637,995,000 after purchasing an additional 1,415,327 shares during the last quarter. Welch & Forbes LLC acquired a new stake in shares of Ralliant in the third quarter worth about $854,000. Finally, Allspring Global Investments Holdings LLC boosted its position in Ralliant by 5,269.9% during the third quarter. Allspring Global Investments Holdings LLC now owns 317,038 shares of the company’s stock worth $14,000,000 after purchasing an additional 311,134 shares during the period.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. Truist Financial decreased their price target on shares of Ralliant from $62.00 to $49.00 and set a “buy” rating for the company in a report on Friday, February 6th. Oppenheimer decreased their price target on shares of Ralliant from $60.00 to $50.00 and set an “outperform” rating on the stock in a research report on Friday, February 6th. Morgan Stanley reissued an “overweight” rating and set a $45.00 price objective on shares of Ralliant in a report on Friday, February 6th. Citigroup lowered their target price on shares of Ralliant from $61.00 to $51.00 and set a “buy” rating on the stock in a research note on Friday, February 6th. Finally, Vertical Research raised Ralliant from a “hold” rating to a “buy” rating and set a $45.00 price objective for the company in a report on Friday, February 6th. Seven equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $50.50.

Insider Transactions at Ralliant

In other Ralliant news, SVP Karen M. Bick sold 5,485 shares of the firm’s stock in a transaction that occurred on Tuesday, March 3rd. The shares were sold at an average price of $45.00, for a total value of $246,825.00. Following the transaction, the senior vice president directly owned 46,756 shares of the company’s stock, valued at approximately $2,104,020. This trade represents a 10.50% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Anelise Angelino Sacks acquired 2,000 shares of the firm’s stock in a transaction that occurred on Monday, February 9th. The shares were bought at an average cost of $41.25 per share, with a total value of $82,500.00. Following the completion of the purchase, the director owned 5,403 shares of the company’s stock, valued at $222,873.75. This trade represents a 58.77% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last quarter, insiders purchased 8,145 shares of company stock valued at $332,233.

Ralliant Stock Performance

Shares of Ralliant stock opened at $42.34 on Friday. The firm has a 50 day simple moving average of $48.24 and a 200 day simple moving average of $46.69. Ralliant Corporation has a fifty-two week low of $37.27 and a fifty-two week high of $57.02. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.84 and a quick ratio of 0.58. The firm has a market cap of $4.73 billion and a P/E ratio of 21.60.

Ralliant (NYSE:RAL) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $0.69 EPS for the quarter, beating analysts’ consensus estimates of $0.67 by $0.02. The firm had revenue of $554.60 million during the quarter, compared to the consensus estimate of $543.04 million. The company’s revenue for the quarter was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 23rd. Shareholders of record on Monday, March 9th will be given a dividend of $0.05 per share. The ex-dividend date is Monday, March 9th. This represents a $0.20 dividend on an annualized basis and a yield of 0.5%. Ralliant’s dividend payout ratio is presently 10.20%.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.